Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805827721> ?p ?o ?g. }
- W2805827721 endingPage "603" @default.
- W2805827721 startingPage "592" @default.
- W2805827721 abstract "Immune-based treatment strategies, such as checkpoint inhibition and chimeric antigen receptor (CAR) T cells, have started a new frontier for treatment in non-Hodgkin lymphoma (NHL). Checkpoint inhibition has been most successful in Hodgkin lymphoma, where higher expression of PD-L1 is correlated with better overall response rate. Combinations of checkpoint inhibition with various chemotherapy or biologics are in clinical trials, with initially promising results and manageable safety profiles. CAR T-cell therapies that target CD19 are a promising and attractive therapy for B-cell NHLs, with a product approved by the US Food and Drug Administration in 2017. Changes in the target, hinge, or costimulatory domain can dramatically alter the persistence and efficacy of the CAR T cells. The ZUMA trials from Kite used CD19-(CD28z) CAR T cells, whereas the TRANSCEND studies from Juno and the JULIET studies from Novartis used CD19-(4-1BBz) CARs. Despite the recent successes with CAR T-cell clinical trials, major concerns associated with this therapy include cytokine release syndrome, potential neurotoxicities, B-cell aplasia, loss of tumor antigen leading to relapse, and cost and accessibility of the treatment. Although first-generation CAR T-cell therapies have failed in solid malignancies, newer second- and third-generation CAR T cells that target antigens other than CD19 (such as mesothelin or B-cell maturation antigen) are being studied in clinical trials for treatment of lung cancer or multiple myeloma. Overall, immune-based treatment strategies have given oncologists and patients hope when there used to be none, as well as a new basket of tools yet to come with further research and development." @default.
- W2805827721 created "2018-06-13" @default.
- W2805827721 creator A5007455653 @default.
- W2805827721 creator A5010130956 @default.
- W2805827721 creator A5022220685 @default.
- W2805827721 creator A5037878906 @default.
- W2805827721 creator A5038196228 @default.
- W2805827721 creator A5054125964 @default.
- W2805827721 creator A5085712310 @default.
- W2805827721 date "2018-05-01" @default.
- W2805827721 modified "2023-09-23" @default.
- W2805827721 title "Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin Lymphoma" @default.
- W2805827721 cites W1500781157 @default.
- W2805827721 cites W1647507681 @default.
- W2805827721 cites W1719275795 @default.
- W2805827721 cites W1842126375 @default.
- W2805827721 cites W1966542058 @default.
- W2805827721 cites W1971424591 @default.
- W2805827721 cites W1977949161 @default.
- W2805827721 cites W1979182989 @default.
- W2805827721 cites W1985328622 @default.
- W2805827721 cites W1986354050 @default.
- W2805827721 cites W1991890073 @default.
- W2805827721 cites W2006436161 @default.
- W2805827721 cites W2009709218 @default.
- W2805827721 cites W2020099065 @default.
- W2805827721 cites W2028240672 @default.
- W2805827721 cites W2035910432 @default.
- W2805827721 cites W2051274722 @default.
- W2805827721 cites W2064510700 @default.
- W2805827721 cites W2069834626 @default.
- W2805827721 cites W2076991609 @default.
- W2805827721 cites W2079365532 @default.
- W2805827721 cites W2082708772 @default.
- W2805827721 cites W2087857484 @default.
- W2805827721 cites W2094945699 @default.
- W2805827721 cites W2097175022 @default.
- W2805827721 cites W2099570622 @default.
- W2805827721 cites W2100158834 @default.
- W2805827721 cites W2117614828 @default.
- W2805827721 cites W2120020619 @default.
- W2805827721 cites W2122465970 @default.
- W2805827721 cites W2125616358 @default.
- W2805827721 cites W2129702476 @default.
- W2805827721 cites W2130338247 @default.
- W2805827721 cites W2142424393 @default.
- W2805827721 cites W2146059841 @default.
- W2805827721 cites W2164433065 @default.
- W2805827721 cites W2170513194 @default.
- W2805827721 cites W2187430385 @default.
- W2805827721 cites W2321985702 @default.
- W2805827721 cites W2337659275 @default.
- W2805827721 cites W2412725897 @default.
- W2805827721 cites W2465734185 @default.
- W2805827721 cites W2471662063 @default.
- W2805827721 cites W2473498748 @default.
- W2805827721 cites W2504623699 @default.
- W2805827721 cites W2509364267 @default.
- W2805827721 cites W2514468425 @default.
- W2805827721 cites W2566677727 @default.
- W2805827721 cites W2586276931 @default.
- W2805827721 cites W2593533764 @default.
- W2805827721 cites W2600581432 @default.
- W2805827721 cites W2602369513 @default.
- W2805827721 cites W2605626471 @default.
- W2805827721 cites W2605683323 @default.
- W2805827721 cites W2608093278 @default.
- W2805827721 cites W2609973112 @default.
- W2805827721 cites W2612422239 @default.
- W2805827721 cites W2617763104 @default.
- W2805827721 cites W2621249739 @default.
- W2805827721 cites W2634656227 @default.
- W2805827721 cites W2651055861 @default.
- W2805827721 cites W2734836464 @default.
- W2805827721 cites W2739211009 @default.
- W2805827721 cites W2739413729 @default.
- W2805827721 cites W2743083943 @default.
- W2805827721 cites W2746068181 @default.
- W2805827721 cites W2749445644 @default.
- W2805827721 cites W2759643796 @default.
- W2805827721 cites W2765415134 @default.
- W2805827721 cites W2766099382 @default.
- W2805827721 cites W2766206231 @default.
- W2805827721 cites W2767609807 @default.
- W2805827721 cites W2772084440 @default.
- W2805827721 cites W2773065484 @default.
- W2805827721 cites W2773651127 @default.
- W2805827721 cites W2773804840 @default.
- W2805827721 cites W2780983694 @default.
- W2805827721 cites W2782080188 @default.
- W2805827721 cites W2782500168 @default.
- W2805827721 cites W2785021126 @default.
- W2805827721 cites W2785269911 @default.
- W2805827721 cites W2979728399 @default.
- W2805827721 cites W3201540941 @default.
- W2805827721 doi "https://doi.org/10.1200/edbk_200549" @default.
- W2805827721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30231316" @default.
- W2805827721 hasPublicationYear "2018" @default.